PAP
BIOA

Persistent Asset Partners’s BioAge Labs BIOA Stock Holding History

Persistent Asset Partners’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$343K Buy
+510
New +$9.21K 0.1% 154
2026
Q1 		– Sell
-61
Closed -$20.3K – 499
2025
Q4 		$20.3K Buy
+61
New +$541 0.01% 314

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Persistent Asset Partners's BIOA Position: Q2 2026 in Review

Persistent Asset Partners increased its BioAge Labs (BIOA) stake by 146% in Q2 2026, buying an estimated $399K and bringing the position to 37,253 shares worth $913K. The position accounts for 0.27% of the portfolio, ranked #68.

Persistent Asset Partners first reported a position in BIOA in Q4 2025 and has held it in 3 quarters since. The position peaked at $963K in Q4 2025. 151 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Persistent Asset Partners held 37,253 shares of BioAge Labs worth $913K as of Q2 2026.
  • Persistent Asset Partners bought 22,086 BioAge Labs shares in Q2 2026, an estimated $399K.
  • BioAge Labs made up 0.27% of Persistent Asset Partners's portfolio in Q2 2026, its #68 holding.
  • Persistent Asset Partners first reported a position in BioAge Labs in Q4 2025 and has held it in 3 quarters since.
  • Persistent Asset Partners's BioAge Labs position peaked at $963K in Q4 2025.
  • 151 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Persistent Asset Partners's 13F filing for Q2 2026, filed 7 Aug 2026.